Stock Earnings

Question 1

What are Regeneron Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Regeneron Pharmaceuticals Inc has a total asset of $40,558, Net profit of $4,504

Question 2

What are the key financial ratios for REGN?

Accepted Answer

Regeneron Pharmaceuticals Inc's Current ratio is 4.36, has a Net margin is 31.4, sales per share of $132.06.

Question 3

How is Regeneron Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Regeneron Pharmaceuticals Inc data is not available.

Question 4

Is Regeneron Pharmaceuticals Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Regeneron Pharmaceuticals Inc has a net profit of $4,504

Question 5

Does Regeneron Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Regeneron Pharmaceuticals Inc has liability of 9,301

Question 6

How many outstanding shares for Regeneron Pharmaceuticals Inc?

Accepted Answer

Regeneron Pharmaceuticals Inc has a total outstanding shares of 105.7

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	14,919	14,342	14,202	13,117	12,172	16,071
Revenue Growth (YoY)	6%	1%	8%	8%	-24%	89%
Cost of Revenue	2,132	1,927	1,844	1,713	1,301	2,205
Gross Profit	12,786	12,415	12,357	11,403	10,871	13,865
Selling, General & Admin	3,366	3,335	2,954	2,631	2,115	1,824
Research & Development	5,414	5,214	5,132	4,439	3,592	2,864
Operating Expenses	8,771	8,540	8,139	7,068	5,618	4,643
Other Non Operating Income (Expenses)	18	33	15	-20	219	50
Pretax Income	5,156	5,230	4,779	4,199	4,858	9,325
Income Tax Expense	689	681	367	245	520	1,250
Net Income	4,423	4,504	4,412	3,953	4,338	8,075
Net Income Growth	-2%	2%	12%	-9%	-46%	130%
Shares Outstanding (Diluted)	107.7	108.6	115.1	113.7	113.5	112.2
Shares Change (YoY)	-3%	-6%	1%	0%	1%	-3%
EPS (Diluted)	41.07	41.48	38.34	34.77	38.22	71.97
EPS Growth	2%	8%	10%	-9%	-47%	136%
Free Cash Flow	3,791	3,765	3,538	3,667	3,398	6,529
Free Cash Flow Per Share	35.19	34.66	30.73	32.25	29.93	58.19
Gross Margin	85.7%	86.56%	87%	86.93%	89.31%	86.27%
Operating Margin	26.91%	27.01%	29.7%	33.04%	43.14%	57.38%
Profit Margin	29.64%	31.4%	31.06%	30.13%	35.63%	50.24%
Free Cash Flow Margin	25.41%	26.25%	24.91%	27.95%	27.91%	40.62%
EBITDA	4,555	4,417	4,700	4,756	5,593	9,508
EBITDA Margin	30.53%	30.79%	33.09%	36.25%	45.94%	59.16%
D&A For EBITDA	540	543	482	421	341	286
EBIT	4,015	3,874	4,218	4,335	5,252	9,222
EBIT Margin	26.91%	27.01%	29.7%	33.04%	43.14%	57.38%
Effective Tax Rate	13.36%	13.02%	7.67%	5.83%	10.7%	13.4%

Regeneron Pharmaceuticals Inc (REGN) Price